Integrated Biopharma Inc SEC filings INBP

Integrated Biopharma Inc has 557 filings in SEC EDGAR's recent list, going back to Nov 21, 1996. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 8, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (results of operations). The company's fiscal year ends on June 30.

Form Description Filed Period
S-8 Employee stock plan registration Dec 28, 2018 —
424B3 Prospectus May 6, 2008 —
S-3/A Integrated biopharma, inc. Apr 29, 2008 —
S-3/A Integrated biopharma, inc. Apr 17, 2008 —
S-3/A Integrated biopharma, inc. Apr 16, 2008 —
S-3 Shelf registration Mar 21, 2008 —
S-3 Shelf registration Jun 28, 2007 —
S-3/A S-3/a integrated biopharma, inc. Feb 8, 2005 —
S-3 Shelf registration Dec 23, 2004 —
S-3/A Integrated biopharma, inc. May 19, 2004 —
S-3 Shelf registration May 12, 2004 —
S-8 Employee stock plan registration May 2, 2002 —
S-8 Employee stock plan registration May 2, 2002 —
S-8 Employee stock plan registration Oct 9, 1997 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INBP (OTC)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Hillside, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1016504
Former names
INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.